// App-Quantinova.ai

3256 : Highly potent monoclonal and bispecific anti-angiogenic antibodies to VEGF and angiopoietin-2

Researchers

Presenter

  • Hangil Park

Principal Investigators

  • April Zhang

  • Yi Ding

  • Lihong Wang

  • Zhengran Wang

  • Maximiliano Vasquez

  • Cary Queen

  • Jin Kim

Medical Centers

  • Galaxy Biotech, LLC, Sunnyvale, CA.

Locations

  • United States

Companies

  • Galaxy Biotech, LLC

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Vascular endothelial growth factor A

Drug/Treatment

  • Bevacizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved